Morinaga

Morinaga Milk Industry is a leading Japanese company specializing in dairy products, infant formula, and therapeutic nutrition with a strong emphasis on life sciences. The company is a global leader in probiotic research, particularly known for its proprietary strains like Bifidobacterium longum BB536 and Bifidobacterium breve M-16V, which are used in clinical and consumer health applications. Beyond functional foods, Morinaga operates a dedicated pharmaceutical division that develops and markets ethical drugs, diagnostic reagents, and medical nutrition products. Its R&D efforts focus on the gut-brain axis, immune modulation, and the health benefits of milk-derived bioactives such as lactoferrin. The company maintains a significant presence in the global market through its subsidiaries and extensive international partnerships. Its pharmaceutical portfolio includes licensed treatments for digestive health and proprietary diagnostic kits.